Literature DB >> 17047100

Immunopathogenesis of IBD: insufficient suppressor function in the gut?

I L Huibregtse1, A U van Lent, S J H van Deventer.   

Abstract

Mesh：

Year:  2006        PMID： 17047100      PMCID： PMC1856872          DOI： 10.1136/gut.2006.103523

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  111 in total

Review 1.  The Nod2 gene in Crohn's disease: implications for future research into the genetics and immunology of Crohn's disease.

Authors:  J H Cho
Journal:  Inflamm Bowel Dis       Date:  2001-08       Impact factor: 5.325

2.  Colonic expression and synthesis of interleukin 13 and interleukin 15 in inflammatory bowel disease.

Authors:  B Vainer; O H Nielsen; J Hendel; T Horn; I Kirman
Journal:  Cytokine       Date:  2000-10       Impact factor: 3.861

3.  Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.

Authors:  L Steidler; W Hans; L Schotte; S Neirynck; F Obermeier; W Falk; W Fiers; E Remaut
Journal:  Science       Date:  2000-08-25       Impact factor: 47.728

4.  Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease.

Authors:  G Monteleone; A Kumberova; N M Croft; C McKenzie; H W Steer; T T MacDonald
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

5.  Activation of natural killer T cells by alpha-galactosylceramide in the presence of CD1d provides protection against colitis in mice.

Authors:  L J Saubermann; P Beck; Y P De Jong; R S Pitman; M S Ryan; H S Kim; M Exley; S Snapper; S P Balk; S J Hagen; O Kanauchi; K Motoki; T Sakai; C Terhorst; Y Koezuka; D K Podolsky; R S Blumberg
Journal:  Gastroenterology       Date:  2000-07       Impact factor: 22.682

6.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.

Authors:  J P Hugot; M Chamaillard; H Zouali; S Lesage; J P Cézard; J Belaiche; S Almer; C Tysk; C A O'Morain; M Gassull; V Binder; Y Finkel; A Cortot; R Modigliani; P Laurent-Puig; C Gower-Rousseau; J Macry; J F Colombel; M Sahbatou; G Thomas
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

7.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.

Authors:  Y Ogura; D K Bonen; N Inohara; D L Nicolae; F F Chen; R Ramos; H Britton; T Moran; R Karaliuskas; R H Duerr; J P Achkar; S R Brant; T M Bayless; B S Kirschner; S B Hanauer; G Nuñez; J H Cho
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

8.  Up-regulation of the IL-12 receptor beta 2 chain in Crohn's disease.

Authors:  T Parrello; G Monteleone; S Cucchiara; I Monteleone; L Sebkova; P Doldo; F Luzza; F Pallone
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

9.  Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells.

Authors:  H Jonuleit; E Schmitt; G Schuler; J Knop; A H Enk
Journal:  J Exp Med       Date:  2000-11-06       Impact factor: 14.307

10.  Treatment of experimental (Trinitrobenzene sulfonic acid) colitis by intranasal administration of transforming growth factor (TGF)-beta1 plasmid: TGF-beta1-mediated suppression of T helper cell type 1 response occurs by interleukin (IL)-10 induction and IL-12 receptor beta2 chain downregulation.

Authors:  A Kitani; I J Fuss; K Nakamura; O M Schwartz; T Usui; W Strober
Journal:  J Exp Med       Date:  2000-07-03       Impact factor: 14.307
View more
  12 in total

1.  Progress in the diagnosis and treatment of inflammatory bowel disease.

Authors:  Edward V Loftus
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-02

Review 2.  Immunopathogenesis of IBD: current state of the art.

Authors:  Heitor S P de Souza; Claudio Fiocchi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-12-02       Impact factor: 46.802

Review 3.  New insights into the role of fatty acids in the pathogenesis and resolution of inflammatory bowel disease.

Authors:  Darla R Shores; David G Binion; Bruce A Freeman; Paul R S Baker
Journal:  Inflamm Bowel Dis       Date:  2010-12-03       Impact factor: 5.325

4.  Gene and cell therapy based treatment strategies for inflammatory bowel diseases.

Authors:  Sander van der Marel; Anna Majowicz; Sander van Deventer; Harald Petry; Daniel W Hommes; Valerie Ferreira
Journal:  World J Gastrointest Pathophysiol       Date:  2011-12-15

5.  Heme oxygenase-1 ameliorates dextran sulfate sodium-induced acute murine colitis by regulating Th17/Treg cell balance.

Authors:  Liya Zhang; Yanjie Zhang; Wenwei Zhong; Caixia Di; Xiaoliang Lin; Zhenwei Xia
Journal:  J Biol Chem       Date:  2014-08-11       Impact factor: 5.157

6.  RNA regulators of host immunity and pathogen adaptive responses in the oral cavity.

Authors:  Jens Kreth; Nan Liu; Zhiyun Chen; Justin Merritt
Journal:  Microbes Infect       Date:  2015-03-17       Impact factor: 2.700

Review 7.  Helminth infections and host immune regulation.

Authors:  Henry J McSorley; Rick M Maizels
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

Review 8.  Colitis-associated cancer: the role of T cells in tumor development.

Authors:  Maximilian J Waldner; Markus F Neurath
Journal:  Semin Immunopathol       Date:  2009-06-03       Impact factor: 9.623

9.  Lactobacillus paracasei reduces intestinal inflammation in adoptive transfer mouse model of experimental colitis.

Authors:  Manuel Oliveira; Nabil Bosco; Genevieve Perruisseau; Jeanne Nicolas; Iris Segura-Roggero; Stéphane Duboux; Muriel Briand; Stéphanie Blum; Jalil Benyacoub
Journal:  Clin Dev Immunol       Date:  2011-07-25

10.  Anti-inflammatory effect of recreational exercise in TNBS-induced colitis in rats: role of NOS/HO/MPO system.

Authors:  Zita Szalai; András Szász; István Nagy; László G Puskás; Krisztina Kupai; Adél Király; Anikó Magyariné Berkó; Anikó Pósa; Gerda Strifler; Zoltán Baráth; Lajos I Nagy; Renáta Szabó; Imre Pávó; Zsolt Murlasits; Mariann Gyöngyösi; Csaba Varga
Journal:  Oxid Med Cell Longev       Date:  2014-02-06       Impact factor: 6.543
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.